Table 1: Demographic, clinical characteristics, and studied parameters of all participants.

Groups/parametersControlLiver disease
1273

Age (years)51 ± 3.7 52.4 ± 5.8NS
Gender (M/F) 6/648/25NS
BMI (Kg/m2)23 ± 1.6 28.7 ± 5.2
BMI (18.5–24.9), lean (%)12 (100%) 37 (51%)
BMI (30–35), obese (%)0 36 (49%)
ASC/fibrosis/cirrhosis20/20/33
Fatty liver 14 (19%)
Portal hypertension* and/or ascites 20 (27%)
HOMA-IR§1.85 (1.63–2)3.28 (2.3–4.7)0.001
IR (%)43 (59%)
TNF-α (pg/mL)§76.6 (43–141)297.0 (205.5– 457.2)<0.0001
Apelin (ng/mL)§1.11 (0.83–1.42)3.25 (2.6–3.9)<0.0001

Data are mean ± S.D, -male to female ratio, § = median (25th and 75th centiles-quartiles). *surrogate markers of portal hypertension, esophageal varices, splenomegaly, and thrombocytopenia.